News | July 10, 2022
China medical devices market to surpass $42 billion in 2022: GlobalData
Domestic devices are usually preferred over imported medical devices in the national or regional procurement.
Domestic devices are usually preferred over imported medical devices in the national or regional procurement.
Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia
Tislelizumab is now approved in nine indications in China
RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
According to GlobalData’s ‘Pharmaceutical Intelligence Center’, the number of diagnosed prevalent cases of ALK-mutant NSCLC in China is estimated to grow at a CAGR of 5.3% from 22,725 in 2021 to 31,902 in 2029
The drug will be available in 600 hospitals and 105 DTPs
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
The demand for high-quality paediatric medicines has been growing rapidly in China as a result of the government’s support and policy measures
CanSinoBIO will continue to focus on developing a variety of innovative preventive vaccines in its diversified product pipeline with proprietary technologies, including the inhaled version of its COVID-19 vaccine, Convidecia
Tislelizumab is now approved for seven indications in China
Subscribe To Our Newsletter & Stay Updated
